Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography: Incidence, malignancy risk, and comparison of standardized uptake values

Canadian Association of Radiologists Journal

Volumn 63, Issue 4, 2012, Pages 289-293

  Kao, Yung H ^a   Lim, Siew S ^b   Ong, Seng C ^c   Padhy, Ajit K ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b SINGHEALTH POLYCLINICS   (Singapore)

^c MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

Author keywords

Cancer; Fine needle aspiration cytology; Fluorine 18 fluorodeoxyglucose positron emission tomography computed tomography; Malignancy risk; Standardized uptake value; Thyroid incidentaloma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER INCIDENCE; CANCER RISK; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CYTOLOGY; DIAGNOSTIC IMAGING; DRUG UPTAKE; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; INCIDENTALOMA; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; REVIEW; THYROID CANCER; THYROID INCIDENTALOMA; THYROID TUMOR; TUMOR DIAGNOSIS;

EID: 84867867724     PISSN: 08465371     EISSN: 14882361     Source Type: Journal    
DOI: 10.1016/j.carj.2011.04.003     Document Type: Article

References (22)

1. K. Ohba, S. Nishizawa, and A. Matsushita High incidence of thyroid cancer in focal thyroid incidentaloma detected by 18F-fluorodeoxyglucose positron emission tomography in relatively young healthy subjects: results of 3-year follow-up Endocr J 57 2010 395 401
2. J.S. Bae, B.J. Chae, and W.C. Park Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer World J Surg Oncol 7 2009 63
3. M.S. Cohen, N. Arslan, and F. Dehdashti Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography Surgery 130 2001 941 946
4. K.W. Kang, S.K. Kim, and H.S. Kang Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects J Clin Endocrinol Metab 88 2003 4100 4104
5. T.Y. Kim, W.B. Kim, and J.S. Ryu 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma Laryngoscope 115 2005 1074 1078
6. C. Are, J.F. Hsu, and H. Schoder FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol 14 2007 239 247
7. J.A. Eloy, E.M. Brett, and G.M. Fatterpekar The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer AJNR Am J Neuroradiol 30 2009 1431 1434
8. C. Are, J.F. Hsu, and R.A. Ghossein Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas Ann Surg Oncol 14 2007 3210 3215
9. D.S. Cooper, G.M. Doherty, and B.R. Haugen Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 2009 1167 1214
10. J.C. Mitchell, F. Grant, and A.R. Evenson Preoperative evaluation of thyroid nodules with 18FDG-PET/CT Surgery 138 2005 1166 1174
11. N.W. Hales, G.A. Krempl, and J.E. Medina Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules? Am J Otolaryngol 29 2008 113 118
12. F.M. Sebastianes, J.J. Cerci, and P.H. Zanoni Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules J Clin Endocrinol Metab 92 2007 4485 4488
13. M. Sasaki, Y. Ichiya, and Y. Kuwabara An evaluation of FDG-PET in the detection and differentiation of thyroid tumours Nucl Med Commun 18 1997 957 963
14. J.M. Kim, J.S. Ryu, and T.Y. Kim 18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm J Clin Endocrinol Metab 92 2007 1630 1634
15. J.Y. Choi, K.S. Lee, and H.J. Kim Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization J Nucl Med 47 2006 609 615
16. U. Feine, R. Lietzenmayer, and J.P. Hanke Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer J Nucl Med 37 1996 1468 1472
17. U. Feine Fluor-18-deoxyglucose positron emission tomography in differentiated thyroid cancer Eur J Endocrinol 138 1998 492 496
18. W. Wang, H. Macapinlac, and S.M. Larson [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels J Clin Endocrinol Metab 84 1999 2291 2302
19. B. Schlüter, K.H. Bohuslavizki, and W. Beyer Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan J Nucl Med 42 2001 71 76
20. R.S. Haber, K.R. Weiser, and A. Pritsker GLUT1 glucose transporter expression in benign and malignant thyroid nodules Thyroid 7 1997 363 367
21. J. Schönberger, J. Rüschoff, and D. Grimm Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: an immunohistochemical study Thyroid 12 2002 747 754
22. Y.W. Kim, I.G. Do, and Y.K. Park Expression of the GLUT1 glucose transporter, p63 and p53 in thyroid carcinomas Pathol Res Pract 202 2006 759 765